Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 118

1.

Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study.

Vickers AJ, Ulmert D, Sjoberg DD, Bennette CJ, Björk T, Gerdtsson A, Manjer J, Nilsson PM, Dahlin A, Bjartell A, Scardino PT, Lilja H.

BMJ. 2013 Apr 15;346:f2023. doi: 10.1136/bmj.f2023.

PMID:
23596126
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study.

Vickers AJ, Cronin AM, Björk T, Manjer J, Nilsson PM, Dahlin A, Bjartell A, Scardino PT, Ulmert D, Lilja H.

BMJ. 2010 Sep 14;341:c4521. doi: 10.1136/bmj.c4521.

PMID:
20843935
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study.

Carlsson S, Assel M, Sjoberg D, Ulmert D, Hugosson J, Lilja H, Vickers A.

BMJ. 2014 Mar 28;348:g2296. doi: 10.1136/bmj.g2296.

PMID:
24682399
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Comparative effectiveness of alternative prostate-specific antigen--based prostate cancer screening strategies: model estimates of potential benefits and harms.

Gulati R, Gore JL, Etzioni R.

Ann Intern Med. 2013 Feb 5;158(3):145-53. doi: 10.7326/0003-4819-158-3-201302050-00003.

PMID:
23381039
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Screening for prostate cancer.

Ilic D, Neuberger MM, Djulbegovic M, Dahm P.

Cochrane Database Syst Rev. 2013 Jan 31;1:CD004720. doi: 10.1002/14651858.CD004720.pub3. Review.

PMID:
23440794
[PubMed - indexed for MEDLINE]
6.

Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: a case-control study.

Ulmert D, Cronin AM, Björk T, O'Brien MF, Scardino PT, Eastham JA, Becker C, Berglund G, Vickers AJ, Lilja H.

BMC Med. 2008 Feb 15;6:6. doi: 10.1186/1741-7015-6-6.

PMID:
18279502
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Baseline prostate-specific antigen measurements and subsequent prostate cancer risk in the Danish Diet, Cancer and Health cohort.

Larsen SB, Brasso K, Iversen P, Christensen J, Christiansen M, Carlsson S, Lilja H, Friis S, Tjønneland A, Dalton SO.

Eur J Cancer. 2013 Sep;49(14):3041-8. doi: 10.1016/j.ejca.2013.04.015. Epub 2013 May 17.

PMID:
23684783
[PubMed - indexed for MEDLINE]
8.

Baseline prostate-specific antigen testing at a young age.

Loeb S, Carter HB, Catalona WJ, Moul JW, Schroder FH.

Eur Urol. 2012 Jan;61(1):1-7. doi: 10.1016/j.eururo.2011.07.067. Epub 2011 Aug 10. Review.

PMID:
21862205
[PubMed - indexed for MEDLINE]
9.

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial.

Hugosson J, Carlsson S, Aus G, Bergdahl S, Khatami A, Lodding P, Pihl CG, Stranne J, Holmberg E, Lilja H.

Lancet Oncol. 2010 Aug;11(8):725-32. doi: 10.1016/S1470-2045(10)70146-7. Epub 2010 Jul 2.

PMID:
20598634
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Comparative efficiency of prostate-specific antigen screening strategies for prostate cancer detection.

Ross KS, Carter HB, Pearson JD, Guess HA.

JAMA. 2000 Sep 20;284(11):1399-405.

PMID:
10989402
[PubMed - indexed for MEDLINE]
11.

Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years.

Lilja H, Ulmert D, Björk T, Becker C, Serio AM, Nilsson JA, Abrahamsson PA, Vickers AJ, Berglund G.

J Clin Oncol. 2007 Feb 1;25(4):431-6.

PMID:
17264339
[PubMed - indexed for MEDLINE]
12.

Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.

Agalliu I, Weiss NS, Lin DW, Stanford JL.

Cancer Causes Control. 2007 Nov;18(9):931-7. Epub 2007 Jul 20.

PMID:
17641982
[PubMed - indexed for MEDLINE]
13.

Population screening for prostate cancer and emerging concepts for young men.

Moul JW.

Clin Prostate Cancer. 2003 Sep;2(2):87-97. Review.

PMID:
15040869
[PubMed - indexed for MEDLINE]
14.

Prostate cancer and prostate-specific antigen (PSA) screening in Austria.

Vutuc C, Schernhammer ES, Haidinger G, Waldhör T.

Wien Klin Wochenschr. 2005 Jul;117(13-14):457-61.

PMID:
16091872
[PubMed - indexed for MEDLINE]
15.

Prostate-specific antigen as predictor of prostate cancer in black men and white men.

Whittemore AS, Lele C, Friedman GD, Stamey T, Vogelman JH, Orentreich N.

J Natl Cancer Inst. 1995 Mar 1;87(5):354-60.

PMID:
7531773
[PubMed - indexed for MEDLINE]
16.

Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.

Andriole GL, Crawford ED, Grubb RL 3rd, Buys SS, Chia D, Church TR, Fouad MN, Isaacs C, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Ragard LR, Clapp JD, Rathmell JM, Riley TL, Hsing AW, Izmirlian G, Pinsky PF, Kramer BS, Miller AB, Gohagan JK, Prorok PC; PLCO Project Team.

J Natl Cancer Inst. 2012 Jan 18;104(2):125-32. doi: 10.1093/jnci/djr500. Epub 2012 Jan 6.

PMID:
22228146
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men.

Klein RJ, Hallden C, Gupta A, Savage CJ, Dahlin A, Bjartell A, Manjer J, Scardino PT, Ulmert D, Wallström P, Vickers AJ, Lilja H.

Eur Urol. 2012 Mar;61(3):471-7. doi: 10.1016/j.eururo.2011.10.047. Epub 2011 Nov 7.

PMID:
22101116
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Outcome following active surveillance of men with screen-detected prostate cancer. Results from the Göteborg randomised population-based prostate cancer screening trial.

Godtman RA, Holmberg E, Khatami A, Stranne J, Hugosson J.

Eur Urol. 2013 Jan;63(1):101-7. doi: 10.1016/j.eururo.2012.08.066. Epub 2012 Sep 5.

PMID:
22980443
[PubMed - indexed for MEDLINE]
19.

Prostate-specific antigen screening and mortality from prostate cancer.

Marcella SW, Rhoads GG, Carson JL, Merlino F, Wilcox H.

J Gen Intern Med. 2008 Mar;23(3):248-53. doi: 10.1007/s11606-007-0479-7. Epub 2008 Jan 3.

PMID:
18172740
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Would prostate cancer detected by screening with prostate-specific antigen develop into clinical cancer if left undiagnosed? A comparison of two population-based studies in Sweden.

Hugosson J, Aus G, Becker C, Carlsson S, Eriksson H, Lilja H, Lodding P, Tibblin G.

BJU Int. 2000 Jun;85(9):1078-84.

PMID:
10848699
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk